These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 7011748)

  • 1. Receptor depletion in diabetes mellitus: correction with therapy.
    Eaton RP; Galagan R; Kaufman E; Allen RC; Russell L; Miller F
    Diabetes Care; 1981; 4(2):299-304. PubMed ID: 7011748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin receptor defect in diabetic man with chronic renal failure: a comparison of erythrocyte insulin binding in diabetic and nondiabetic patients on maintenance hemodialysis.
    Gambhir KK; Nerurkar SG; Cruz IA; Hosten AO
    Biochem Med; 1981 Feb; 25(1):62-73. PubMed ID: 7013759
    [No Abstract]   [Full Text] [Related]  

  • 3. Autophosphorylation of insulin receptor in a patient with Werner's syndrome associated with insulin resistant diabetes mellitus.
    Shima F; Ishida Y; Hotta K; Hagino H; Hozumi T; Shii K; Baba S; Kazumi T
    Endocr J; 1995 Feb; 42(1):107-13. PubMed ID: 7599691
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Insulin cell receptors in diabetes caused by pancreatitis].
    Frati-Munari AC; Rodríguez-Rodríguez J; Altamirano P
    Arch Invest Med (Mex); 1987; 18(2):157-66. PubMed ID: 3310946
    [No Abstract]   [Full Text] [Related]  

  • 5. Erythrocyte insulin receptors in non-insulin-dependent diabetes mellitus.
    DePirro R; Fusco A; Lauro R; Testa I; Ferreti F; DeMartinis C
    Diabetes; 1980 Feb; 29(2):96-9. PubMed ID: 6986305
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Erythrocyte and monocyte insulin binding in man: a comparative analysis in normal and disease states.
    Dons RF; Ryan J; Gorden P; Wachslicht-Rodbard H
    Diabetes; 1981 Nov; 30(11):896-902. PubMed ID: 7028544
    [No Abstract]   [Full Text] [Related]  

  • 7. A case of maturity-onset diabetes mellitus resistant to insulin but responsive to tolbutamide.
    Rendell M; Slevin D; Meltz G; Simpson J; Barquet A
    Ann Intern Med; 1979 Feb; 90(2):195-7. PubMed ID: 443652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Erythrocyte receptors of insulin].
    Thomopoulos P; Testa U; Vainchenker W
    Journ Annu Diabetol Hotel Dieu; 1982; ():19-30. PubMed ID: 7098247
    [No Abstract]   [Full Text] [Related]  

  • 9. Erythrocyte insulin binding in a family with hereditary motor sensory neuropathy (Charcot-Marie-Tooth) with superimposed insulin-dependent type I diabetes mellitus.
    Ivarsson SA; Bjerre I
    Diabetes Res; 1989 Jan; 10(1):49-51. PubMed ID: 2667841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin binding to erythrocytes in diabetic patients.
    Okamoto M; Kuzuya H; Seino Y; Ikeda M; Imura H
    Endocrinol Jpn; 1981 Apr; 28(2):169-73. PubMed ID: 7030723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Erythrocyte insulin receptors technics and clinical applications].
    Rizkalla SW; Le Bouc Y; Desplanque N; Weissbrodt P; Serog P; Apfelbaum M; Slama G; Tchobroutsky G
    Journ Annu Diabetol Hotel Dieu; 1982; ():45-52. PubMed ID: 7047841
    [No Abstract]   [Full Text] [Related]  

  • 12. Severe hyperprolactinaemia is associated with decreased insulin binding in vitro and insulin resistance in vivo.
    Schernthaner G; Prager R; Punzengruber C; Luger A
    Diabetologia; 1985 Mar; 28(3):138-42. PubMed ID: 3888755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erythrocytes: a new cell type for the evaluation of insulin receptor defects in diabetic humans.
    Robinson TJ; Archer JA; Gambhir KK; Hollis VW; Carter L; Bradley C
    Science; 1979 Jul; 205(4402):200-2. PubMed ID: 451590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erythrocyte insulin binding abnormalities in fibro calculous pancreatic diabetes.
    Ramachandran A; Susheela L; Mohan V; Kuzali DA; Viswanathan M
    Horm Metab Res; 1988 Nov; 20(11):693-7. PubMed ID: 3063650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of metformin treatment on erythrocyte insulin binding in normal weight subjects, in obese non diabetic subjects, in type 1 and type 2 diabetic patients.
    Rizkalla SW; Elgrably F; Tchobroutsky G; Slama G
    Diabete Metab; 1986 Aug; 12(4):219-24. PubMed ID: 3533670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin binding to erythrocytes in diabetes mellitus.
    Okada Y; Arima T; Okazaki S; Nakata K; Yamabuki T; Nagashima H
    Acta Med Okayama; 1981 Oct; 35(4):273-7. PubMed ID: 6457514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin binding of erythrocytes in hypoinsulinemic diabetics and its relationship to metabolic states.
    Oka Y; Ezaki O; Akanuma Y; Kosaka K
    Endocrinol Jpn; 1981 Oct; 28(5):615-22. PubMed ID: 7047154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Behavior of the serum I.R.I. in persons with latent diabetes after endovenous tolbutamide load].
    Artenisio AC; Albanese MC; Allegra V; Alibrando S; Caruso A; Sprovieri M; Corsi V
    Folia Endocrinol; 1972 Aug; 25(4):300-11. PubMed ID: 4678219
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of long-term tolbutamide treatment on glucose tolerance and insulin secretion in maturity-onset diabetes without obesity.
    Lauvaux JP; Mandart G; Heymans G; Ooms HA
    Horm Metab Res; 1972 Mar; 4(2):58-62. PubMed ID: 5028221
    [No Abstract]   [Full Text] [Related]  

  • 20. Therapeutic effect of tolbutamide in non-insulin dependent diabetes mellitus (NIDDM). Relation to beta-cell function.
    Damsgaard EM; Faber O; Frøland A; Iversen S
    Acta Endocrinol (Copenh); 1982 Jul; 100(3):416-20. PubMed ID: 7051723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.